In most metastatic bone tumor lesions, the differentiation of osteoclast from BMMs are mainly mediated by activation of NF-κB pathway, which initiated by factors secreted in bone microenvironment by cancer cells and osteoblasts 41. This evidence concerns the gene NFKB1 and cancer.